• COVID-19 Phase 2 topline report to be submitte

• COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week

Pretty bold statement?

Foreshadowing maybe that approval is coming. Interesting.